Seeing Beneath the Surface: Skin Clues to Systemic Disease in Patients With Skin of Color
There is more than meets the eye when it comes to diagnosing dermatologic disease. At the most recent Skin of Color Update conference in New York City, co-chair Dr. Andrew Alexis gave a case-based presentation on dermatologic clues to systemic disease in patients with skin of color. The cases highlighted how subtle pigmentary and textural changes in the skin can be the first presenting sign of …
There is more than meets the eye when it comes to diagnosing dermatologic disease. At the most recent Skin of Color Update conference in New York City, co-chair Dr. Andrew Alexis gave a case-based presentation on dermatologic clues to systemic disease in patients with skin of color. The cases highlighted how subtle pigmentary and textural changes in the skin can be the first presenting sign of … 
Histopathology can be rendered useless without good clinical information, according to Dr. Olayemi Sokumbi, a dermatologist and dermatopathologist with Mayo Clinic. Next Steps in Derm, in partnership with ODAC Dermatology, Aesthetic & Surgical Conference, interviewed Dr. Sokumbi about traps to avoid in challenging clinicopathologic scenarios. Learn how not to miss a diagnosis of dermatomyosit … 
ABSTRACT
Dyschromia is a concern for many patients, especially persons of color. Postinflammatory hypopigmentation and depigmentation can affect all skin types; however, it is more apparent in those with darker skin. Some members of the dermatology community may not comprehensively understand the mechanisms of these reactions and the extent of the psychosocial effect they have on persons of color … 
Collagen vascular diseases encompass a group of autoimmune disorders that can have a profound impact on an individual's health and quality of life. At the 2023 Skin of Color Update, Dr. Ted Rosen, Professor and Vice-Chair of Dermatology at Baylor College of Medicine, explained how these conditions uniquely impact individuals with skin of color.
Missed the lecture?? Explore key insights and pear … 
Intravenous immune globulin (IVIG) is a concentrate of pooled immunoglobulins derived from plasma donors. Its unique mechanism of action expands the utility of the medication to a variety of conditions. We continue our series, Therapeutic Cheat Sheet, with a closer look at IVIG, which is FDA-approved for the treatment of dermatologic conditions including dermatomyositis, Kawasaki disease, ITP, and …